TRIB is Trinity Biotech plc (Healthcare) — a non-dividend-paying stock. Trading at $9.60. Market cap: $8M.
Stock snapshot
| Price | $9.60 |
| Market cap | $8M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About TRIB
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
Related non-dividend companies
Other non-dividend stocks investors research alongside TRIB. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is TRIB's current stock price?
TRIB (Trinity Biotech plc) is currently trading at $9.60.
Does TRIB pay a dividend?
TRIB (Trinity Biotech plc) does not currently pay a regular dividend.
Track TRIB in DiviDrip
Add TRIB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search TRIB and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.